What is Wolverine Stack?

The Peptides Collective Wolverine Stack vial contains BPC-157 and TB-500 at a listed strength of 10mg, from A$85. ^[1] A stack in our catalogue is a single vial holding more than one compound, as grouped in the peptide stacks collection. ^[1]

The Wolverine Stack 10mg product page identifies the two components. ^[1] Their molecular identifiers belong to each peptide, so they should be recorded separately when documenting the material. ^[2][3]

The catalogue gives the vial strength and component names, but does not specify the mass of each component or their ratio. ^[1] Check those details before calculating a component-specific laboratory concentration.

BPC-157 and TB-500 research includes reviews, cell work and animal studies, with limited human BPC-157 reports and human thymosin beta-4 studies that concern the full-length molecule. ^[2][3] A rat Achilles tendon study names both BPC-157 and TB-500. ^[8]

The distinction between a component, a combination and a related molecule changes what a paper can tell you. ^[1][3] Full-length thymosin beta-4 has 43 residues in its mature chain; TB-500 has seven. ^[3] Human findings for the full-length molecule cannot establish findings for the Peptides Collective two-component vial. ^[1][3]

The rat combination study establishes that the pairing has been examined in an animal model. ^[8] Its captured record supplies the title, year and model, without numerical findings, group sizes or a formulation match to the commercial vial. ^[8] It does not justify a claim that the two-component product has a demonstrated human outcome. ^[8]

There is no separately labelled TB-500 cell-study record in this evidence set; the animal-labelled 2024 paper includes in vitro experiments. ^[14] No controlled human study of the TB-500 fragment or the Wolverine Stack vial is included. ^[5] The BPC-157 record likewise reports no identified controlled human clinical trial. ^[2]

Two small uncontrolled human BPC-157 pilots reported no adverse events or side effects, while a full-length thymosin beta-4 trial reported infrequent mild or moderate adverse events. ^[12][16][15] Their study populations and materials do not establish an adverse-event profile for the TB-500 fragment or the Wolverine Stack vial. ^[1][3]

The BPC-157 pilots had no control group and shared a first author. ^[12][16] A 2025 narrative review states that only three human pilot studies had examined BPC-157 and that rigorous large-scale trials were lacking (PMID 40789979). ^[18] An absence of reported events in these small reports leaves substantial uncertainty. ^[18]

Another human study examined full-length thymosin beta-4 in 73 patients with venous stasis ulcers (PMID 20536470). ^[19] Its captured abstract excerpt gives a comparison with placebo without listing event types or counts, so a specific adverse-event breakdown cannot be given from it. ^[19]

No human adverse-event study of the TB-500 fragment was identified in the captured research record. ^[5] Keep the full-length molecule's reports separate from the fragment's evidence. ^[3]

BPC-157 and TB-500 are each listed in Schedule 4 and Appendix D clause 5 of the June 2026 Poisons Standard, checked on 29 September 2026. ^[6] The listing applies to the named components in Wolverine Stack. ^[1][6]

Appendix D clause 5 lists substances for which possession without authority is an offence. ^[6] The instrument is F2026L00633, the June 2026 Poisons Standard, which commenced on 1 June 2026. ^[6] Our Australian peptide legal guide provides the broader scheduling context.

The WADA 2026 list took effect on 1 January 2026. ^[7] It names BPC-157 under S0 and “Thymosin-beta4 and its derivatives e.g. TB-500” under S2.3. ^[7] Australian scheduling and anti-doping classification are separate records, and both need to remain attached to the component names. ^[6][7]

For laboratory handling of Wolverine Stack, check the batch and mass basis, select a compatible solvent, dissolve gently, then label and store the solution. ^[20] This four-step summary depends on knowing what the vial contains and how its mass is reported. ^[1][20]

Our peptide reconstitution guide describes warming the sealed vial to room temperature before opening, cleaning the stoppers, adding solvent down the glass wall and swirling gently. ^[20] Record the compound names, batch number, solvent, concentration and date. ^[20]

Concentration in mg/mL equals peptide mass in mg divided by solvent volume in mL. ^[20] For a blend, calculating each peptide's concentration requires its individual mass, which the catalogue does not specify. ^[1][20] HPLC purity and net peptide content are distinct measurements, so a purity percentage alone does not resolve the mass basis. ^[20]

The peptide storage guide recommends keeping sealed lyophilised material dry and dark at -20°C or colder for long-term storage, with 2 to 8°C for short-term storage. ^[21] It recommends 2 to 8°C for reconstituted working solutions and avoiding repeated freezing and thawing. ^[21]

The house guide keeps BAC Water solutions refrigerated and reserves frozen aliquots for compatible plain-water or buffered solutions. ^[21] Its solvent-specific caution draws on antibody research, and it states that no equivalent short-peptide study was found. ^[21] Neither handling guide supplies a measured shelf life for the Wolverine Stack blend. ^[20][21]

You can check the analytical record for your Wolverine Stack batch: Peptides Collective uses an independent third-party laboratory before sale, with purity by HPLC and identity by mass spectrometry. ^[4] The certificate is available on request using the compound, strength and batch number. ^[4]

Read about the methods on our testing page and use the certificate of analysis page to request the report for the batch you intend to order. ^[4]

A batch certificate ties the analytical findings to one batch. ^[20] Match its batch number to the vial and read the reported identity and purity findings. ^[20] A certificate for another batch does not describe the material in your vial. ^[20]

Orders dispatch from Perth twice daily Monday to Friday and once on Saturday, after payment clears. ^[4] Every order has thermal insulation and plain outer packaging. ^[4]

WA courier delivery costs A$15 and is free on WA orders over A$150. ^[4] Outside WA, the listed charge is A$24 with tracking and a signature required. ^[4] The shipping information sets out the delivery options. Dispatch frequency describes when orders leave Perth; arrival depends on the courier. ^[4]

Our pick is the Peptides Collective Wolverine Stack vial: batch tested by an independent lab, certificate on request, fast tracked dispatch from Perth. ^[4] The reason to choose it is the documented testing and local supply process; the research remains component-specific and largely preclinical. ^[4][2][3] Request the batch report and confirm the component masses before recording laboratory concentrations.